Authors:
Brada, M
Hoang-Xuan, K
Rampling, R
Dietrich, PY
Dirix, LY
Macdonald, D
Heimans, JJ
Zonnenberg, BA
Bravo-Marques, JM
Henriksson, R
Stupp, R
Yue, N
Bruner, J
Dugan, M
Rao, S
Zaknoen, S
Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266
Authors:
Vermeulen, PB
Colpaert, C
Salgado, R
Royers, R
Hellemans, H
Van den Heuvel, E
Goovaerts, G
Dirix, LY
Van Marck, E
Citation: Pb. Vermeulen et al., Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia, J PATHOLOGY, 195(3), 2001, pp. 336-342
Authors:
Kvinnsland, S
Anker, G
Dirix, LY
Bonneterre, J
Prove, AM
Wilking, N
Lobelle, JP
Mariani, O
di Salle, E
Polli, A
Massimini, G
Citation: S. Kvinnsland et al., High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment, EUR J CANC, 36(8), 2000, pp. 976-982
Authors:
Kaufmann, M
Bajetta, E
Dirix, LY
Fein, LE
Jones, SE
Cervek, J
Fowst, C
Polli, A
Di Salle, E
Massimini, G
Piscitelli, G
Citation: M. Kaufmann et al., Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial, EUR J CANC, 36, 2000, pp. S86-S87
Authors:
Kaufmann, M
Bajetta, E
Dirix, LY
Fein, LE
Jones, SE
Zilembo, N
Dugardyn, JC
Nasurdi, C
Mennel, RG
Cervek, J
Fowst, C
Polli, A
di Salle, E
Arkhipov, A
Piscitelli, G
Miller, LL
Massimini, G
Citation: M. Kaufmann et al., Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial, J CL ONCOL, 18(7), 2000, pp. 1399-1411
Authors:
Salgado, R
Benoy, I
Weytjens, R
Vermeulen, PB
Dirix, LY
Citation: R. Salgado et al., Serum vascular endothelial growth factor load and interleukin-6 in cancer patients - reply, BR J CANC, 82(11), 2000, pp. 1896-1896
Authors:
Gasparini, G
Toi, M
Miceli, R
Vermeulen, PB
Dittadi, R
Biganzoli, E
Morabito, A
Fanelli, M
Gatti, C
Suzuki, H
Tominaga, T
Dirix, LY
Gion, M
Citation: G. Gasparini et al., Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy, CA J SCI AM, 5(2), 1999, pp. 101-111
Authors:
Salgado, R
Vermeulen, PB
Benoy, I
Weytjens, R
Huget, P
Van Marck, E
Dirix, LY
Citation: R. Salgado et al., Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients, BR J CANC, 80(5-6), 1999, pp. 892-897
Authors:
Vermeulen, PB
Van den Eynden, GG
Huget, P
Goovaerts, G
Weyler, J
Lardon, F
Van Marck, E
Hubens, G
Dirix, LY
Citation: Pb. Vermeulen et al., Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer, BR J CANC, 79(2), 1999, pp. 316-322